Cell therapies: Bringing it all together from early technology evaluations to commercial approval

To view the webinar, please login to your account.

No account yet? Register.

Brought to you by the CAR-TCR Digital Week, in partnership with Lonza

During this round table digital event, a panel of experts shares insights when evaluating and advancing cell therapies from translation to the clinical trials and beyond. The moderator focuses the discussion on current and future trends along with evaluating technology platforms, raw materials, and manufacturing challenges. The session closes with a discussion of how to better meet these challenges within this rapidly evolving space.

Panelists

Dr. Laurence Cooper
CEO, Ziopharm Oncology, Inc.
Boston, MA, USA

Dr. Isabelle Riviere
Director Cell Therapy and Cell Engineering Facility
Memorial Sloan Kettering Cancer Center
New York, NY, USA

Dr. Steve Feldman
Director of Manufacturing and Process Development
Center for Cancer Cell Therapy, Stanford University
Stanford, CA, USA

Dr. Eytan Abraham
Head of Personalized Medicine
Lonza Pharma&Biotech
Walkersville, MD, USA

Discover how Lonza can support your path from discovery to commercialization